Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells ; volume:17 ; number:1 ; day:11 ; month:12 ; year:2021 ; pages:1-16 ; date:12.2021
BMC veterinary research ; 17, Heft 1 (11.12.2021), 1-16, 12.2021
- Urheber
-
Bernard, Sarah
Poon, Andrew C.
Tam, Peyton M.
Mutsaers, Anthony J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12917-021-03089-0
- URN
-
urn:nbn:de:101:1-2022021818291647649879
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bernard, Sarah
- Poon, Andrew C.
- Tam, Peyton M.
- Mutsaers, Anthony J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
A Systematic Review of Rapamycin- Mediated Fetal Hemoglobin Induction via the mTOR Pathway
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
A Systematic Review of Rapamycin- Mediated Fetal Hemoglobin Induction via the mTOR Pathway
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
mTOR inhibitor everolimus reduces invasiveness of melanoma cells
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas